# Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

> **NCT03403569** · PHASE3 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 353 (actual)

## Conditions studied

- HIV-infection/AIDS

## Interventions

- **DRUG:** Triptolide Wilfordii
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03403569
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-06-30
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2022-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03403569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03403569, "Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03403569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*